Healthcare: 3 Tough Luck Tumbles – Are They Buys?

Industry Focus - A podcast by The Motley Fool

Categories:

Business

Spark Therapeutics, Rite Aid, and Alnylam shares have tumbled following news, but that doesn’t necessarily make all three stocks worth buying. Stocks: ONCE, RAD, ALNY